A. Lensing

发表

The Long-Term Clinical Course of Acute Deep Venous Thrombosis

Paolo Prandoni, M. Prins, P. Prandoni, 1996, Annals of Internal Medicine.

Treatment of Pulmonary Embolism With Rivaroxaban: Outcomes by Simplified Pulmonary Embolism Severity Index Score from a Post Hoc Analysis of the EINSTEIN PE Study

M. Prins, J. Kline, P. Wells, 2015, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

Diagnosis of deep-vein thrombosis using an objective Doppler method.

H. Büller, J. T. ten Cate, P. Prandoni, 1990 .

Diagnostic management of venous thromboembolism.

H. Büller, J. T. ten Cate, E. Van Beek, 1998, Bailliere's clinical haematology.

Deep Vein Thrombosis: New Non-Invasive Diagnostic Tests

J. Hirsh, H. Büller, J. T. ten Cate, 1991, Thrombosis and Haemostasis.

Noninvasive objective tests for the diagnosis of clinically suspected deep-vein thrombosis.

P. Prandoni, P. Wells, A. Cogo, 1995, Haemostasis.

Detection of deep-vein thrombosis by real-time B-mode ultrasonography.

H. Büller, J. T. ten Cate, P. Prandoni, 1989, The New England journal of medicine.

Lower extremity venography with iohexol: results and complications.

H. Büller, J. T. ten Cate, P. Prandoni, 1990, Radiology.

Comparison of Real-Time B-Mode Ultrasonography and Doppler Ultrasound with Contrast Venography in the Diagnosis of Venous Thrombosis in Symptomatic Outpatients

H. Büller, J. T. ten Cate, P. Prandoni, 1993, Thrombosis and Haemostasis.

A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients.

H. Büller, J. T. ten Cate, A. Turpie, 1993, The New England journal of medicine.

The Diagnostic Value of Compression Ultrasonography in Patients with Suspected Recurrent Deep Vein Thrombosis

P. Prandoni, E. Bernardi, A. Girolami, 2002, Thrombosis and Haemostasis.

Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials.

M. Prins, P. Prandoni, P. Wells, 2014, The Lancet. Haematology.

Bleeding risk of patients with acute venous thromboembolism taking nonsteroidal anti-inflammatory drugs or aspirin.

M. Prins, A. Lensing, T. Brighton, 2014, JAMA internal medicine.

Anticoagulation in acute ischaemic stroke: deep vein thrombosis prevention and long-term stroke outcomes.

A. Lensing, 1999, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Residual Venous Thrombosis as a Predictive Factor of Recurrent Venous Thromboembolism

M. Prins, P. Prandoni, E. Bernardi, 2002, Annals of Internal Medicine.

Long-term outcomes after deep venous thrombosis of the lower extremities

P. Prandoni, M. Prins, A. Lensing, 1998, Vascular medicine.

Deep-vein thrombosis and the incidence of subsequent symptomatic cancer.

M. Prins, H. Büller, J. T. ten Cate, 1992, The New England journal of medicine.

Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis.

M. Prins, J. Hirsh, A. Lensing, 1995, Archives of internal medicine.

Safety of Low-Molecular-Weight Heparin in Pregnancy: A Systematic Review

B. Brenner, M. Prins, H. Büller, 1999, Thrombosis and Haemostasis.

Reduction in the length of stay with rivaroxaban as a single-drug regimen for the treatment of deep vein thrombosis and pulmonary embolism

M. Prins, A. Lensing, L. Bamber, 2014, Current medical research and opinion.

Distribution of thrombosis in patients with symptomatic deep vein thrombosis. Implications for simplifying the diagnostic process with compression ultrasound.

J. Hirsh, P. Prandoni, A. Cogo, 1993, Archives of internal medicine.

Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program

M. Prins, A. Hirayama, K. Iekushi, 2015, Thrombosis Journal.

Pharmacokinetic and clinical data supporting the use of fondaparinux 1.5 mg once daily in the prevention of venous thromboembolism in renally impaired patients

A. Turpie, T. Fuji, A. Lensing, 2009, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial

M. Prins, A. Turpie, A. Cohen, 2006, BMJ : British Medical Journal.

Sex‐specific differences in clot resolution 3 weeks after acute pulmonary embolism managed with anticoagulants—A substudy of the EINSTEIN‐PE study

S. Middeldorp, A. Lensing, Á. Pap, 2021, Journal of thrombosis and haemostasis : JTH.

Clot resolution after 3 weeks of anticoagulant treatment for pulmonary embolism: comparison of computed tomography and perfusion scintigraphy

H. Büller, P. Wells, P. Verhamme, 2013, Journal of thrombosis and haemostasis : JTH.

The Use of the D-Dimer Test in Combination with Non-Invasive Testing Versus Serial Non-Invasive Testing Alone for the Diagnosis of Deep-Vein Thrombosis

H. Büller, H. Heijboer, Jeffrey S. Ginsberg, 1992, Thrombosis and Haemostasis.

Health‐care Cost Impact of Continued Anticoagulation With Rivaroxaban vs Aspirin for Prevention of Recurrent Symptomatic VTE in the EINSTEIN‐CHOICE Trial Population

M. Prins, Yongling Xiao, P. Prandoni, 2018, Chest.

The long term clinical course of acute deep vein thrombosis of the arm: prospective cohort study

M. Prins, P. Prandoni, E. Bernardi, 2004, BMJ : British Medical Journal.

Limitations of compression ultrasound for the detection of symptomless postoperative deep vein thrombosis

H. Büller, A. Lensing, M. Koopman, 1994, The Lancet.

Use of Prestudy Heparin Did Not Influence the Efficacy and Safety of Rivaroxaban in Patients Treated for Symptomatic Venous Thromboem‐bolism in the EINSTEIN DVT and EINSTEIN PE Studies

M. Prins, P. Prandoni, A. Lensing, 2015, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

D-dimer testing to determine the duration of anticoagulation therapy.

A. Iorio, A. Tosetto, S. Testa, 2006, The New England journal of medicine.

Newly Diagnosed Malignancy in Patients with VenousThromboembolism. Search or Wait and See?

M. Prins, J. Hirsh, A. Lensing, 1997, Thrombosis and Haemostasis.

Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use.

M. Prins, P. Wells, I. Martinelli, 2016, Blood.

Ventilation-Perfusion Lung Scanning and the Diagnosis of Pulmonary Embolism: Improvement of Observer Agreement by the Use of a Lung Segment Reference Chart

J. Hirsh, J. T. ten Cate, G. Coates, 1992, Thrombosis and Haemostasis.

Choosing wisely: The impact of patient selection on efficacy and safety outcomes in the EINSTEIN-DVT/PE and AMPLIFY trials.

M. Prins, P. Prandoni, N. Kucher, 2017, Thrombosis research.

A comparison of compression ultrasound with color Doppler ultrasound for the diagnosis of symptomless postoperative deep vein thrombosis.

J. Hirsh, P. Prandoni, A. Cogo, 1997, Archives of internal medicine.

Subcutaneous Low-Molecular Weight Heparin or Oral Anticoagulants for the Prevention of Deep-Vein Thrombosis in Elective Hip and Knee Replacement?

J. van der Meer, K. Hamulýak, A. Lensing, 1995, Thrombosis and Haemostasis.

Low accuracy of color Doppler ultrasound in the detection of proximal leg vein thrombosis in asymptomatic high-risk patients. The RD Heparin Arthroplasty Group.

C. Elliott, A. Lensing, B. Davidson, 1992, Annals of internal medicine.

[Evaluation of the consensus deep venous thrombosis].

H. Lamberts, M. Huisman, A. Lensing, 1988, Nederlands tijdschrift voor geneeskunde.

Low molecular weight heparin versus unfractionated heparin in the initial treatment of venous thromboembolism.

M. Prins, H. Büller, A. Lensing, 1998, Current opinion in pulmonary medicine.

Low molecular weight heparin: a critical analysis of clinical trials.

M. Prins, J. Hirsh, J. Heit, 1994, Pharmacological reviews.

Below-Knee Elastic Compression Stockings To Prevent the Post-Thrombotic Syndrome

M. Prins, P. Prandoni, E. Bernardi, 2004, Annals of Internal Medicine.

Fondaparinux or Enoxaparin for the Initial Treatment of Symptomatic Deep Venous Thrombosis

G. Raskob, M. Prins, M. Gent, 2004, Annals of Internal Medicine.

Safety of Treatment with Oral Anticoagulants in the Elderly

M. Prins, R. Kraaijenhagen, A. Lensing, 1999, Drugs & aging.

Anticoagulant Treatment in Patients with Cancer and Venous Thrombosis Recurrent Venous Thromboembolism and Bleeding Complications During

M. Prins, P. Prandoni, E. Bernardi, 2013 .

Old antithrombotics: ready to retire?

A. Lensing, C. D. Nicholson, 2001, Expert opinion on investigational drugs.

A dose-finding study of fondaparinux in patients with non-ST-segment elevation acute coronary syndromes: the Pentasaccharide in Unstable Angina (PENTUA) Study.

F. Van de Werf, M. Simoons, A. Vahanian, 2004, Journal of the American College of Cardiology.

Clinical impact and course of major bleeding with rivaroxaban and vitamin K antagonists

H. Büller, S. Middeldorp, M. Levi, 2015, Journal of thrombosis and haemostasis : JTH.

Independent predictors of poor vitamin K antagonist control in venous thromboembolism patients

K. Meijer, A. Lensing, K. Sahin, 2015, Thrombosis and Haemostasis.

A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study.

G. Raskob, M. Prins, G. Agnelli, 2008, Blood.

Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis

M. Prins, E. Casiglia, S. Iliceto, 2006, Journal of thrombosis and haemostasis : JTH.

Study DVT Dose-Ranging - symptomatic deep vein thrombosis: the Einstein factor Xa inhibitor rivaroxaban in the treatment of patients with acute A dose-ranging study evaluating once-daily oral administration of the

G. Raskob, M. Prins, G. Agnelli, 2013 .

Stress-induced hyperglycaemia and venous thromboembolism following total hip or total knee arthroplasty

H. Büller, J. DeVries, S. Kuhls, 2011, Thrombosis and Haemostasis.

Fixed dose subcutaneous low molecular weight heparins versus adjusted dose infractionated heparin for venous thromboembolism [Cochrane review]

M. Prins, A. Lensing, J. DongenvanC.J., 2004 .

Comparison of Four Bleeding Risk Scores to Identify Rivaroxaban‐treated Patients With Venous Thromboembolism at Low Risk for Major Bleeding

M. Prins, J. Kline, D. Courtney, 2016, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

Does the presence of clinical symptoms of pulmonary embolism affect the outcome of patients with deep vein thrombosis?

M. Prins, P. Prandoni, A. Lensing, 2017, Thrombosis research.

Erratum to: ‘Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program’

M. Prins, A. Hirayama, K. Iekushi, 2016, Thrombosis Journal.

Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism

M. Prins, P. Prandoni, P. Wells, 2015, Thrombosis and Haemostasis.

The Impact of Residual Thrombosis on the Long-Term Outcome of Patients with Deep Venous Thrombosis Treated with Conventional Anticoagulation

M. Prins, P. Prandoni, R. Pesavento, 2015, Seminars in Thrombosis & Hemostasis.

Rivaroxaban for the treatment of symptomatic deep-vein thrombosis and pulmonary embolism in Chinese patients: a subgroup analysis of the EINSTEIN DVT and PE studies

M. Prins, K. Ying, A. Lensing, 2013, Thrombosis Journal.

O R I G I N a L C L I N I C a L I N V E S T I G a T I O N Open Access

M. Prins, A. Lensing, 2022 .

Residual Thrombosis on Ultrasonography to Guide the Duration of Anticoagulation in Patients With Deep Venous Thrombosis: A Randomized Trial

W. Ageno, M. Prins, P. Prandoni, 2009 .

Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin.

M. Prins, P. Prandoni, P. Wells, 2018, Thrombosis research.

Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension.

G. Raskob, M. Prins, P. Prandoni, 2016, Chest.

Treatment of venous thromboembolism with rivaroxaban in relation to body weight

M. Prins, P. Prandoni, M. Di Nisio, 2016, Thrombosis and Haemostasis.

Prevention of Deep Vein Thrombosis after Hip Replacement

H. Büller, M. Samama, J. Barrê, 1999, Thrombosis and Haemostasis.

Low-dose heparin for severe sepsis.

W. Geerts, A. Lensing, B. Davidson, 2002, The New England journal of medicine.

Risk of recurrent venous thromboembolism according to baseline risk factor profiles.

M. Prins, P. Prandoni, P. Wells, 2018, Blood advances.

Ultrasonography to Guide Duration of Anticoagulation in DVT

M. Prins, P. Prandoni, A. Lensing, 2009 .

Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutationRisk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis

M. Prins, P. Prandoni, P. Simioni, 2000 .

Rivaroxaban versus standard anticoagulation for acute venous thromboembolism in childhood. Design of the EINSTEIN-Jr phase III study

M. Prins, P. Monagle, S. Berkowitz, 2018, Thrombosis Journal.

The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients.

G. Raskob, M. Prins, P. Prandoni, 2018, Thrombosis research.

Patient-Reported Treatment Satisfaction with Oral Rivaroxaban Versus Standard Therapy in the Treatment of Acute Symptomatic Pulmonary Embolism

M. Prins, S. Cano, A. Lensing, 2012 .

Prevalence and risk of preexisting heparin-induced thrombocytopenia antibodies in patients with acute VTE.

M. Prins, H. Büller, M. Gent, 2011, Chest.

Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT).

M. Prins, P. Monagle, I. Martinelli, 2020, Blood advances.

Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE).

M. Prins, P. Monagle, S. Berkowitz, 2020, Blood advances.

Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein‐Jr phase 3 dose‐exposure‐response evaluation

M. Prins, P. Monagle, I. Martinelli, 2019, Journal of thrombosis and haemostasis : JTH.

Safety and e ﬃ cacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT) the EINSTEIN-Jr Cerebral trial

M. Prins, P. Monagle, I. Martinelli, 2020 .

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.

M. Prins, P. Monagle, I. Martinelli, 2019, The Lancet. Haematology.

Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies.

M. Prins, P. Monagle, I. Martinelli, 2019, The Lancet. Haematology.

Clinical presentation and therapeutic management of venous thrombosis in young children: a retrospective analysis

P. Monagle, S. Berkowitz, G. Young, 2018, Thrombosis Journal.

Exploratory evaluation of pharmacodynamics, pharmacokinetics and safety of rivaroxaban in children and adolescents: an EINSTEIN-Jr phase I study

P. Monagle, L. Brandão, I. Martinelli, 2018, Thrombosis Journal.

Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study

J. Lippert, R. Burghaus, S. Willmann, 2018, Thrombosis Journal.

Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin/vitamin K antagonists for acute deep-vein thrombosis

M. Prins, P. Prandoni, P. Verhamme, 2016, Thrombosis and Haemostasis.

Influence of statin use on the incidence of recurrent venous thromboembolism and major bleeding in patients receiving rivaroxaban or standard anticoagulant therapy

M. Prins, P. Wells, A. Lensing, 2014, Thrombosis Journal.

fixed-dose rivaroxaban is not associated with increased recurrent venous thromboembolism or major bleeding in patients with a high or low body weight : As099

M. Prins, A. Riera-Mestre, A. Lensing, 2015 .

Effect of polypharmacy on bleeding with rivaroxaban versus vitamin K antagonist for treatment of venous thromboembolism

M. Prins, S. Middeldorp, A. Lensing, 2022, Journal of thrombosis and haemostasis : JTH.

Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism.

Paolo Prandoni, Sabino Iliceto, Vittorio Pengo, 2004, The New England journal of medicine.

Shortened length of hospital stay with rivaroxaban in patients with symptomatic venous thromboembolism in Japan: the J-EINSTEIN pulmonary embolism and deep vein thrombosis program

M. Prins, H. Matsuo, A. Lensing, 2015, Current medical research and opinion.

Other Uses of LMWHs – Miscellaneous

Paolo Prandoni, Mark Levine, Frederick R. Rickles, 1998, Pathophysiology of Haemostasis and Thrombosis.

Prevalence of Pulmonary Embolism among Patients Hospitalized for Syncope.

Paolo Prandoni, Stefano Campostrini, Davide Imberti, 2016, The New England journal of medicine.

On the True Prevalence of Pulmonary Embolism in Patients Hospitalized for a First Syncopal Event.

M. Prins, P. Prandoni, A. Lensing, 2019, Journal of the American College of Cardiology.

A New Computerized Impedance Plethysmograph: Accuracy in the Detection of Proximal Deep-Vein Thrombosis in Symptomatic Outpatients

H. Büller, J. T. ten Cate, P. Prandoni, 1991, Thrombosis and Haemostasis.

Failure of Computerized Impedance Plethysmography in the Diagnostic Management of Patients with Clinically Suspected Deep-Vein Thrombosis

H. Büller, J. T. ten Cate, P. Prandoni, 1991, Thrombosis and Haemostasis.

Elastic compression stockings for prevention of the post-thrombotic syndrome in patients with and without residual vein thrombosis and/or popliteal valve reflux

M. Prins, P. Prandoni, G. Palareti, 2021, Haematologica.

Is contrast venography a valid surrogate outcome measure in venous thromboembolism prevention studies?

M. Prins, A. Lensing, A. Segers, 2005, Journal of thrombosis and haemostasis : JTH.

Cost comparison of continued anticoagulation with rivaroxaban versus placebo based on the 1-year EINSTEIN-Extension trial efficacy and safety results

Yongling Xiao, J. Schein, P. Wells, 2018, Journal of medical economics.

Post-thrombotic syndrome and the risk of subsequent recurrent thromboembolism.

M. Prins, P. Prandoni, A. Lensing, 2016, Thrombosis research.

Should Patients with Deep Vein Thrombosis Alone be Treated as Those with Concomitant Asymptomatic Pulmonary Embolism? A Prospective Study

H. Büller, M. Monreal, A. Lensing, 2002, Thrombosis and Haemostasis.

Recurrent deep vein thrombosis and two coagulation factor gene mutations: quo vadis?

M. Prins, A. Lensing, 1999, Thrombosis and haemostasis.

The use of specific antidotes as a response to bleeding complications during anticoagulant therapy for venous thromboembolism

M. Prins, H. Büller, D. Haverkamp, 2003, Journal of thrombosis and haemostasis : JTH.

PK/PD modeling of FXI antisense oligonucleotides to bridge the dose‐FXI activity relation from healthy volunteers to end‐stage renal disease patients

S. Bhanot, R. Yu, R. Geary, 2021, CPT: pharmacometrics & systems pharmacology.

Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials

G. Raskob, H. Büller, M. Gent, 2007, Journal of thrombosis and haemostasis : JTH.

Determinants of severe post-thrombotic syndrome: The role of thrombus location.

M. Prins, P. Prandoni, A. Lensing, 2019, Thrombosis research.

Residual vein thrombosis and the risk of subsequent serious complications.

M. Prins, P. Prandoni, A. Lensing, 2015, Thrombosis research.

proximal-venous thrombosis : a randomized trial prevention of the postthrombotic syndrome in patients with Thigh-length versus below-knee compression elastic stockings for

M. Prins, P. Prandoni, B. Cosmi, 2012 .

Relevance of Inherited Risk Factors in Young Patients with Deep-Vein Thrombosis

P. Prandoni, E. Bernardi, A. Cogo, 1996 .

Prolonged Prophylaxis after Joint Replacement: Another Step Sideways?

A. Lensing, B. Davidson, 2000, Annals of Internal Medicine.

Oral rivaroxaban for symptomatic venous thromboembolism.

Bruce L Davidson, Giancarlo Agnelli, Sebastian Schellong, 2010, The New England journal of medicine.

Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism.

M. Prins, A. Lensing, M. Prins, 2004, The Cochrane database of systematic reviews.

Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high‐ and low‐dose rivaroxaban with aspirin

M. Prins, P. Prandoni, I. Martinelli, 2021, Research and Practice in Thrombosis and Haemostasis.

Graduated compression stockings in the prevention of postoperative venous thromboembolism. A meta-analysis.

J. Hirsh, P. Wells, A. Lensing, 1994, Archives of internal medicine.

Low-molecular-weight heparin and the survival of patients with advanced malignancy.

M. Prins, H. Büller, P. Prandoni, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Non-Invasive Diagnostic Techniques in Deep Vein Thrombosis

H. Büller, M. Huisman, A. Lensing, 1988 .

Surrogate Endpoints for the Assessment of Efficacy in Venous Thromboembolism Treatment Trials

A. Lensing, 1998, Pathophysiology of Haemostasis and Thrombosis.

Confirmation of the Failure of Computerized Impedance Plethysmography in the Diagnostic Management of Patients with Clinically Suspected Deep-Vein Thrombosis

H. Büller, J. T. ten Cate, P. Prandoni, 1991, Thrombosis and Haemostasis.

Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of acute symptomatic deep-vein thrombosis

M. Prins, S. Cano, A. Lensing, 2013, Thrombosis and Haemostasis.

Prevention of Deep Vein Thrombosis after Hip Replacement

H. Büller, M. Samama, A. Lensing, 2017 .

[Thrombosis diagnosis in Noord-Holland in 1985].

H. Büller, J. T. ten Cate, M. Levi, 1986, Nederlands tijdschrift voor geneeskunde.

Accuracy of compression ultrasound in screening for deep venous thrombosis in acutely ill medical patients

K. Oniszh, P. Kuca, A. Lensing, 2007, Thrombosis and Haemostasis.

[Unreliability of the clinical diagnosis of deep venous thrombosis of the legs. A prospective study].

P. Prandoni, A. Lensing, S. Cuppini, 1988, Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna.

Residual venous thrombosis and recurrent thromboembolism. Authors' reply

M. Prins, V. Rajput, P. Prandoni, 2003 .

Deep Vein Thrombosis and Fibrinolysis

H. Büller, J. T. ten Cate, P. Prandoni, 1991, Thrombosis and Haemostasis.

An association between atherosclerosis and venous thrombosis.

M. Prins, P. Prandoni, E. Bernardi, 2003, The New England journal of medicine.

Extended anticoagulant therapy in venous thromboembolism: a balanced, fractional factorial, clinical vignette-based study

M. Prins, P. Prandoni, P. Wells, 2019, Haematologica.

Idiopathic deep venous thrombosis. Is a search for malignant disease justified?

M. Prins, J. Hirsh, A. Lensing, 1994, Archives of internal medicine.

Family history of venous thrombosis or sudden death as a risk factor for venous thromboembolism

M. Prins, P. Prandoni, A. Lensing, 2012, Thrombosis and Haemostasis.

The effect of low molecular weight heparin on survival in patients with advanced malignancy.

Susanne M. Smorenburg, M. Prins, H. Büller, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bleeding Classification in Clinical Trials: Observer Variability and Clinical Relevance

M. Prins, H. Büller, R. D. de Haan, 1997, Thrombosis and Haemostasis.

Population pharmacokinetic analysis of rivaroxaban in children and comparison to prospective physiologically‐based pharmacokinetic predictions

Yang Zhang, J. Lippert, P. Zhu, 2021, CPT: pharmacometrics & systems pharmacology.

Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.

M Gent, M H Prins, H R Büller, 2003, The New England journal of medicine.

125I-Fibrinogen Leg Scanning: Reassessment of Its Role for the Diagnosis of Venous Thrombosis in Post-Operative Patients

J. Hirsh, A. Lensing, 1993, Thrombosis and Haemostasis.

Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

Paolo Prandoni, Antonio Girolami, Paolo Simioni, 2002, Blood.

Rivaroxaban: population pharmacokinetic analyses in patients treated for acute deep-vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention.

Paolo Prandoni, Giancarlo Agnelli, P. Prandoni, 2011, Clinical pharmacokinetics.

Rivaroxaban: a novel oral anticoagulant for the prevention and treatment of several thrombosis‐mediated conditions

C. Nessel, S. Berkowitz, Guohua Pan, 2013, Annals of the New York Academy of Sciences.

Graduated Compression Stockings for the Prevention of Post-operative Venous Thromboembolism

J. Hirsh, P. Wells, Philip Wells, 2001 .

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

M. Prins, P. Prandoni, P. Wells, 2017, The New England journal of medicine.

Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies

G. Raskob, M. Prins, P. Wells, 2013, Thrombosis Journal.

Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism.

M. Prins, Á. Atallah, A. Lensing, 2000, The Cochrane database of systematic reviews.

Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis

M. Prins, H. Büller, P. Prandoni, 2019, BMJ.

Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis

H. Büller, P. Prandoni, A. Cogo, 1992, The Lancet.

O R I G I N a L C L I N I C a L I N V E S T I G a T I O N Open Access

M. Prins, A. Lensing, Anthonie WA., 2022 .

Deep-vein thrombosis

M. Prins, P. Prandoni, A. Lensing, 1999, The Lancet.

Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort study

H. Büller, P. Prandoni, P. Wells, 1998, BMJ.

Prevalence of pulmonary embolism among patients with recent onset of dyspnea on exertion. A cross-sectional study.

W. Ageno, M. Prins, P. Prandoni, 2023, Journal of thrombosis and haemostasis : JTH.

Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of pulmonary embolism; results from the EINSTEIN PE trial.

M. Prins, S. Cano, A. Lensing, 2015, Thrombosis research.

Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism

G. Raskob, W. Ageno, H. Büller, 2021, Annals of Internal Medicine.

Long‐term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta‐analysis

G. Raskob, W. Ageno, H. Büller, 2021, Journal of thrombosis and haemostasis : JTH.

Erratum to: Rivaroxaban: population pharmacokinetic analyses in patients treated for acute deep-vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention

P. Prandoni, G. Agnelli, H. Décousus, 2011, Clinical Pharmacokinetics.

Accuracy of Ultrasound for the Diagnosis of Deep Venous Thrombosis in Asymptomatic Patients after Orthopedic Surgery

J. Hirsh, P. Wells, A. Lensing, 1995, Annals of Internal Medicine.

Selected Phlebology Abstracts

M. Prins, P. Prandoni, B. Cosmi, 2011, Blood.

A simple clinical model for the diagnosis of deep‐vein thrombosis combined with impedance plethysmography: potential for an improvement in the diagnostic process

J. Hirsh, P. Prandoni, P. Wells, 1998, Journal of internal medicine.

Paper1-03 jan 1998

H. Büller, P. Prandoni, A. Turpie, 1997 .

Clinical Utility of Real-Time Compression Ultrasonography for Diagnostic Management of Patients with Recurrent Venous Thrombosis

H. Büller, J. T. ten Cate, H. Heijboer, 1992, Acta radiologica.

Randomised Controlled Trial of Rivaroxaban Compared to Standard Anticoagulants for the Treatment of Acute Venous Thromboembolism in Children

M. Peters, M. Prins, P. Monagle, 2019, Social Science Research Network.

Anticoagulation in pediatric cancer–associated venous thromboembolism: a subgroup analysis of EINSTEIN-Jr

M. Prins, P. Monagle, L. Brandão, 2022, Blood advances.

UvA-DARE ( Digital Academic Repository ) Venous thromboembolism , coagulation and cancer

G. Raskob, M. Prins, H. Décousus, 2009 .

Reduction in Initial Length of Stay with Rivaroxaban Single-Drug Regimen versus LMWH-VKA Standard of Care

M. Prins, A. Lensing, L. Bamber, 2012 .

Long-term risk of major bleeding after discontinuing anticoagulation for unprovoked venous thromboembolism: a systematic review and meta-analysis

C. Bradbury, P. Prandoni, B. Hutton, 2021, Thrombosis and Haemostasis.

Should echocardiography of the right ventricle help determine who receives thrombolysis for pulmonary embolism?

A. Lensing, B. Davidson, 2001, Chest.

The risk of recurrent venous thromboembolism and major bleeding in fragile patients with deep vein thrombosis

M. Prins, H. Büller, P. Verhamme, 2011 .

Venous thrombotic burden and the risk of subsequent overt cancer

M. Prins, P. Prandoni, A. Piccioli, 2015, Thrombosis and Haemostasis.

Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairment

M. Prins, P. Prandoni, H. Décousus, 2014, Thrombosis Journal.

Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis.

H. Büller, M. Vermeulen, S. D. de Bruijn, 1999, Stroke.

O R I G I N a L C L I N I C a L I N V E S T I G a T I O N Open Access

G. Raskob, M. Prins, P. Wells, 2022 .

Rivaroxaban for the treatment of symptomatic deep-vein thrombosis and pulmonary embolism in Chinese patients: a subgroup analysis of the EINSTEIN DVT and PE studies

M. Prins, K. Ying, A. Lensing, 2013, Thrombosis Journal.

Ultrasonography of contralateral veins in patients with unilateral deep-vein thrombosis

P. Prandoni, A. Girolami, A. Piccioli, 1998, The Lancet.

The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden).

M. Prins, P. Prandoni, P. Simioni, 1997, The New England journal of medicine.

Low molecular weight heparin: a critical analysis of clinical trials.

J. Heit, A. Lensing, B. Davidson, 1994, Pharmacological Reviews.

Residual Venous Thrombosis and Recurrent Thromboembolism

M. Prins, P. Prandoni, A. Lensing, 2003 .

Graduated compression stockings in the prevention of postoperative venous thromboembolism. A meta-analysis.

J. Hirsh, P. Wells, A. Lensing, 1994, Archives of internal medicine.

Prevalence of Pulmonary Embolism among Patients Hospitalized for Syncope.

M. Prins, P. Prandoni, S. Campostrini, 2016, The New England journal of medicine.

Bleeding risk of patients with acute venous thromboembolism taking nonsteroidal anti-inflammatory drugs or aspirin.

M. Prins, A. Lensing, T. Brighton, 2014, JAMA internal medicine.

Treatment of venous thromboembolism with rivaroxaban in relation to body weight

M. Prins, P. Prandoni, P. Wells, 2016, Thrombosis and Haemostasis.

Pulmonary Embolism in Patients Hospitalized for Syncope.

M. Prins, P. Prandoni, A. Lensing, 2017, The New England journal of medicine.

Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

M. Prins, P. Prandoni, E. Bernardi, 2002, Blood.

The Impact of Residual Thrombosis on the Long-Term Outcome of Patients with Deep Venous Thrombosis Treated with Conventional Anticoagulation

M. Prins, P. Prandoni, R. Pesavento, 2015, Seminars in Thrombosis & Hemostasis.

Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis

M. Prins, H. Büller, P. Prandoni, 2019, BMJ.

Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis.

M. Prins, P. Prandoni, P. Simioni, 2000, Blood.

Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial.

W. Ageno, M. Prins, P. Prandoni, 2009, Annals of internal medicine.